Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hawaiian Electric Industries
HE
|
+$139M |
| 2 |
GE Aerospace
GE
|
+$128M |
| 3 |
NVIDIA
NVDA
|
+$100M |
| 4 |
Citizens Financial Group
CFG
|
+$99M |
| 5 |
Molson Coors Class B
TAP
|
+$97.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CF Industries
CF
|
+$89.6M |
| 2 |
Booking.com
BKNG
|
+$82.6M |
| 3 |
Domino's
DPZ
|
+$81.9M |
| 4 |
Apple
AAPL
|
+$81.9M |
| 5 |
American International
AIG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.32% |
| 2 | Healthcare | 13.45% |
| 3 | Consumer Discretionary | 13.43% |
| 4 | Industrials | 12.23% |
| 5 | Financials | 11.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Primoris Services
PRIM
$4.08B
| $1.6M | ﹤0.01% |
48,825
+24,698
| +102% | +$807K |
|
1427
MacroGenics
MGNX
$262M
| $1.59M | ﹤0.01% |
340,610
+120,263
| +55% | +$599K |
|
1428
Shutterstock
SSTK
$199M
| $1.58M | ﹤0.01% |
41,620
+36,590
| +727% | +$1.64M |
|
1429
Petrobras Class A
PBR.A
$103B
| $1.57M | ﹤0.01% |
114,852
+5,235
| +5% | +$67.5K |
|
1430
ArcBest
ARCB
$3.05B
| $1.56M | ﹤0.01% |
15,371
-6,345
| -29% | -$666K |
|
|
ITCI
1431
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.56M | ﹤0.01% |
29,939
+13,793
| +85% | +$804K |
|
1432
JPMorgan BetaBuilders Japan ETF
BBJP
$19B
| $1.56M | ﹤0.01% |
+31,000
| New | +$1.59M |
|
1433
Mesa Laboratories
MLAB
$696M
| $1.55M | ﹤0.01% |
14,714
+6,546
| +80% | +$839K |
|
1434
Limbach Holdings
LMB
$509M
| $1.54M | ﹤0.01% |
+48,604
| New | +$1.47M |
|
1435
Voyager Therapeutics
VYGR
$217M
| $1.54M | ﹤0.01% |
+198,822
| New | +$1.82M |
|
1436
Enanta Pharmaceuticals
ENTA
$433M
| $1.54M | ﹤0.01% |
137,776
+118,320
| +608% | +$1.91M |
|
1437
Badger Meter
BMI
$3.89B
| $1.54M | ﹤0.01% |
10,673
-348
| -3% | -$55K |
|
1438
GrafTech
EAF
$169M
| $1.53M | ﹤0.01% |
40,021
+9,736
| +32% | +$407K |
|
1439
IES Holdings
IESC
$12.9B
| $1.53M | ﹤0.01% |
46,508
+25,420
| +121% | +$827K |
|
1440
Veracyte
VCYT
$3.45B
| $1.53M | ﹤0.01% |
68,435
+16,269
| +31% | +$418K |
|
|
SAGE
1441
DELISTED
Sage Therapeutics
SAGE
| $1.53M | ﹤0.01% |
74,183
+63,058
| +567% | +$1.82M |
|
1442
Caleres
CAL
$443M
| $1.53M | ﹤0.01% |
53,037
-16,393
| -24% | -$435K |
|
1443
Kulicke & Soffa
KLIC
$4.42B
| $1.52M | ﹤0.01% |
31,343
-7,739
| -20% | -$410K |
|
1444
Freshworks
FRSH
$3.41B
| $1.52M | ﹤0.01% |
+76,378
| New | +$1.52M |
|
|
ZUO
1445
DELISTED
Zuora, Inc.
ZUO
| $1.52M | ﹤0.01% |
184,186
+134,668
| +272% | +$1.33M |
|
1446
iHeartMedia
IHRT
$415M
| $1.51M | ﹤0.01% |
477,171
-327,027
| -41% | -$1.23M |
|
1447
Workiva
WK
$4.03B
| $1.51M | ﹤0.01% |
+14,876
| New | +$1.55M |
|
1448
Progyny
PGNY
$1.96B
| $1.5M | ﹤0.01% |
44,126
+3,836
| +10% | +$145K |
|
1449
Vicor
VICR
$9.01B
| $1.5M | ﹤0.01% |
25,430
-46,983
| -65% | -$3.11M |
|
1450
Motorcar Parts of America
MPAA
$222M
| $1.5M | ﹤0.01% |
184,825
+64,936
| +54% | +$537K |
|
Similar funds
Cliff Asness's Q3 2023 Portfolio in Review
As of Q3 2023, Cliff Asness held 2,432 positions worth $48.4B, up 2.9% from $47B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Cliff Asness deployed $2.75B of net new capital in Q3 2023, opening 254 new positions and adding to 1,140 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was CF Industries, an estimated $89.6M trimmed.
- Cliff Asness's largest Q3 2023 buy was Vanguard FTSE Developed Markets ETF: 624,491 shares worth $27.3M.
- Cliff Asness added most to Hawaiian Electric Industries in Q3 2023, an estimated $139M increase.
- Cliff Asness's biggest Q3 2023 reduction was CF Industries, cutting an estimated $89.6M.
- Cliff Asness fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $60.5M.
- Cliff Asness's ten largest holdings make up 14% of its $48.4B portfolio in Q3 2023.
- Cliff Asness opened 254 new positions and closed 123 in Q3 2023.
- Cliff Asness's portfolio value rose 2.9% quarter-over-quarter to $48.4B.
Based on AQR Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.